SBIR/STTR Research Award

Labeling method for high-resolution imaging of hundreds of tissue antigens

Award identifier 1d70f445d0625e4f3e6a86f86449286b56629ac47087baa034ac7942fbcbd250Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$225,000

Program and phase

SBIR · Phase I

Award year

2015

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
ARATOME, LLC
Proposal award date
2015-04-01
Contract end date
2016-12-31
UEI
Not reported
Solicitation number
PA14-071
Topic code
105

Research abstract

DESCRIPTION provided by applicant Neurodegenerative diseases are among the most expensive disruptive and least well treated of human maladies arguably because they are not well understood Array tomography AT is a new method for tissue imaging with resolution in all three dimensions sufficient to resolve individual synapses and provide quantitative characterization of multple molecular constituents AT imaging data enable description of neural networks in the ontext of the three dimensional tissue architecture We believe such data will enable researchers to begin o comprehend the proper function of neural circuits and importantly to begin to undestand how it is that the various neurodegenerative processes present and progress AT is however complex and expensive and has been used in relatively few studies following the first publication in by Micheva and Smith Aratome is currently providing AT services to the research community The present application proposes proof of concept studies of a novel direct labeling method that could be the basis of a fully automated AT system analogous to a NextGen Sequencer The sample would be loaded into a microfluidic chamber placed on the imaging instrument and imaging data for tens tohundreds of antigens would be acquired automatically We would develop such an instrument as well as the catalog of directly labeled antibody and detection reagents under Phase funding PUBLIC HEALTH RELEVANCE Neurodegenerative diseases including Alzheimerandapos s and Parkinsonandapos s are becoming increasingly prevalent as the population ages Efforts to develop treatments for these diseases have been hampered by a lack of basic understanding of the disease processes due in part to the lack of technologies that provide quantitative information regarding the disease progression We propose a method for fully automated high resolution proteomic analysis of the brain to better understand these pathologies which should enable the development of more effective treatments

Technology keywords

Not reported

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.